Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide
Iris Maria Forte(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonio Giordano(University of Siena)
Cited by 42
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1
|Cell Death and Differentiation|2012|76